Clinical behavior of desmoid tumors
Don’t metastasize but are locally aggressive
Precipitants of desmoid tumors
1) High estrogen states - during or following pregnancy (extra-abdominal or abdominal)
2) Trauma
3) FAP
Clinical course of desmoid tumors
highly variable clinical course (stable to spontaneously regressing to slow growing to rapidly progressive)
Management of desmoid tumor
Management of gross residual disease after resection of a desmoid tumor
Management of large intra-abdominal desmoid tumors in the setting of Gardner syndrome
Klinefelter presentation
New drug approved for RET translocated sarcoma
selpercatinib
New drug approved for desmoid tumors
nirogacestat
Drug to know for giant cell tumor of bone
denosumab
Drug recently approved for alveolar soft part sarcoma
atezolizumab
Drug to know for tenosynovial giant cell tumor + major SE to be aware of
Drug approved for advanced epithelioid sarcoma
tazometastat
Osteosarcoma age distribution
bimodal (smaller peak in 60-80)
Radiographic features of osteosarcoma
Biopsy required for osteosarcoma
Osteosarcoma preferred staging modalities
Major prognostic indicator in osteosarcoma
Management of high grade localized osteosarcoma (most are high grade)
neoadjuvant chemo
Surgery
+/- adjuvant
Management of low grade localized osteosarcoma
surgery alone
Neoadjuvant systemic therapy for osteosarcoma
3 cycles of doxorubicin + cisplatin
*high dose methotrexate can be added if young with good renal function
First line chemotherapy for metastatic osteosarcoma
Doxorubicin based
Cisplatin/doxorubicin without high dose methotrexate
Second line for metastatic osteosarcoma
Ifosfamide +/- etoposide
Oligometastatic paradigm exist in osteosarcoma